AG
DNA icon

Algert Global’s Ginkgo Bioworks DNA Stock Holding History

Algert Global’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
180,060
+96,110
+114% +$804K 0.02% 869
2026
Q1 		$515K Sell
83,950
-68,210
-45% -$567K 0.01% 964
2025
Q4 		$1.26M Buy
+152,160
New +$1.64M 0.02% 805
2024
Q3 		– Sell
-2,695
Closed -$36K – 1278
2024
Q2 		$36K Buy
+2,695
New +$80.4K ﹤0.01% 1460
2022
Q3 		– Sell
-1,512
Closed -$144K – 1205
2022
Q2 		$144K Buy
+1,512
New +$184K 0.01% 1069

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Algert Global's DNA Position: Q2 2026 in Review

Algert Global increased its Ginkgo Bioworks (DNA) stake by 114% in Q2 2026, buying an estimated $804K and bringing the position to 180,060 shares worth $1.78M. The position accounts for 0.02% of the portfolio, ranked #869.

Algert Global first reported a position in DNA in Q2 2022 and has held it in 5 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Algert Global held 180,060 shares of Ginkgo Bioworks worth $1.78M as of Q2 2026.
  • Algert Global bought 96,110 Ginkgo Bioworks shares in Q2 2026, an estimated $804K.
  • Ginkgo Bioworks made up 0.02% of Algert Global's portfolio in Q2 2026, its #869 holding.
  • Algert Global first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 5 quarters since.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.